Phase 2 Clinical Trials

Known as: 2 clinical phase trials, ii phase trials, Clinical Trials, Phase II 
Works about studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Purpose Most crizotinib-treated patients with anaplastic lymphoma kinase gene ( ALK)-rearranged non-small-cell lung cancer (ALK… (More)
Is this relevant?
Highly Cited
2016
Highly Cited
2016
BACKGROUND A phase 2 study showed that progression-free survival was longer with palbociclib plus letrozole than with letrozole… (More)
Is this relevant?
Highly Cited
2015
Highly Cited
2015
We present response and survival outcomes of a pivotal phase 2 trial of the antibody-drug conjugate brentuximab vedotin in… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Palbociclib (PD-0332991) is an oral, small-molecule inhibitor of cyclin-dependent kinases (CDKs) 4 and 6 with… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE We report two clinical trials in non-small cell lung cancer (NSCLC) patients evaluating immune response, toxicity, and… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Approximately 40–50% of glioblastomas (GBM) overexpress epidermal growth factor receptor (EGFR). Erlotinib is a specific and… (More)
  • table 2
  • table 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE This randomized phase II trial evaluated two docetaxel-based regimens to see which would be most promising according to… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
This multicenter, open-label, randomized phase 2 study evaluated 2 dose regimens of lenalidomide for relapsed, refractory myeloma… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
In a phase 2 study, 62 patients with relapsed and refractory acute myeloid leukemia (AML; n = 31), myelodysplastic syndrome (MDS… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
ChimeriVax-JE is a live, attenuated vaccine against Japanese encephalitis, using yellow fever (YF) 17D vaccine as a vector. In a… (More)
Is this relevant?